Clinical Trials · NCT02904759
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 342
- Start date
- Sep 2016
- Locations
- 1 site, Japan
- Primary endpoint
- Change from baseline in mean number of nocturnal voids during 12 weeks of treatment